Target intelligence / Profile preview

Onychomycosis-causing fungal pathogens

Molecular classification
Other
01

Overview

Fungal cells causing onychomycosis primarily include dermatophytes such as Trichophyton rubrum and Trichophyton mentagrophytes, which account for the majority of cases (StatPearls, 2023). These pathogens also encompass various yeasts, such as Candida albicans, and non-dermatophyte molds that invade the nail unit, including the nail plate and bed (NIH, 2022). The biological role of these cells in disease involves the secretion of keratinases that degrade nail keratin, facilitating fungal colonization and persistence (PubMed, 2021). Pharmacological intervention targets specific molecular pathways within these cells, most notably the ergosterol biosynthetic pathway and protein synthesis machinery (Journal of Fungi, 2021). Drugs like terbinafine and efinaconazole work by inhibiting enzymes like squalene epoxidase and 14-alpha demethylase, respectively, leading to membrane disruption and cell death (FDA, 2020). Because the nail plate acts as a physical barrier, these fungal cells are often difficult to eradicate, requiring long-term systemic or topical therapy (Mayo Clinic, 2023).

Other names
DermatophytesTrichophyton rubrumTrichophyton mentagrophytesCandida albicansNon-dermatophyte moldsNail fungusTinea unguium pathogens
02

Mechanism of action

Antifungal drugs target these cells by inhibiting ergosterol biosynthesis (via squalene epoxidase or 14-alpha demethylase inhibition), disrupting protein synthesis (via leucyl-tRNA synthetase inhibition), or interfering with fungal cell membrane integrity and intracellular transport.

03

Biological functions

Ergosterol biosynthesisCell wall synthesisKeratin degradationFungal growth and replication
04

Disease associations

InfectionOnychomycosisTinea unguium
05

Safety considerations

HepatotoxicityDrug-drug interactions (CYP3A4 inhibition)Local application site reactionsLong treatment durationHigh recurrence rates
06

Interacting drugs

Terbinafine

6 more in the full profile.

07

Biomarkers

KOH preparationFungal culturePAS stainingPCR-based fungal identification

Beyond the preview

Go deeper on Onychomycosis-causing fungal pathogens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Onychomycosis-causing fungal pathogens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call